Skip to search boxSkip to navigationSkip to main content

Mapping the diverse and inclusive future of parkinson’s disease genetics and its widespread impact

  • University of Gezira
    ,
  • UCL Queen Square Institute of Neurology
    ,
  • Universidad Peruana Cayetano Heredia
    ,
  • docencia y atención especializada en epilepsia
    ,
  • National Institute on Aging (NIA)
Research Output:
Contribution to journal
Review article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Review article
Peer-review

Original language

English

Article number

1681

Journal (Volume, Issue Number)

Genes (Volume 12, Issue 11)

Publication milestones

  • Published - 11/2021

Publication status

Published - 11/2021

Publication IDs

  • Scopus: 85119007009
  • PubMed: 34828286

Abstract

Over the last decades, genetics has been the engine that has pushed us along on our voyage to understand the etiology of Parkinson’s disease (PD). Although a large number of risk loci and causative mutations for PD have been identified, it is clear that much more needs to be done to solve the missing heritability mystery. Despite remarkable efforts, as a field, we have failed in terms of diversity and inclusivity. The vast majority of genetic studies in PD have focused on individuals of European ancestry, leading to a gap of knowledge on the existing genetic differences across populations and PD as a whole. As we move forward, shedding light on the genetic architecture contributing to PD in non-European populations is essential, and will provide novel insight into the generalized genetic map of the disease. In this review, we discuss how better representation of understudied ancestral groups in PD genetics research requires addressing and resolving all the challenges that hinder the inclusion of these populations. We further provide an overview of PD genetics in the clinics, covering the current challenges and limitations of genetic testing and counseling. Finally, we describe the impact of worldwide collaborative initiatives in the field, shaping the future of the new era of PD genetics as we advance in our understanding of the genetic architecture of PD.

Funding Details

Funding: This research was supported, in part, by the Intramural Research Program of the National Institutes of Health (National Institute on Aging, National Institute of Neurological Disorders and Stroke: project numbers 1ZIA-NS003154, Z01-AG000949-02 and Z01-ES10198). Acknowledgments: This work was carried out with the support and guidance of ‘GP2 Trainee Network’ which is part of the Global Parkinson’s Disease Genetics Program and funded by the Aligning Science Across Parkinson’s (ASAP) initiative.
FundersFunding numbers
Aligning Science Across Parkinson’s
-
NIH
-
NIA
-
NINDS
Z01-AG000949-02, Z01-ES10198, 1ZIA-NS003154

Publication metrics

Metrics

Scopus
Citations

PlumX, opens in new tab

Mentions
2
Captures
27
Citations
9